ライフサイエンスコーパス: very low birth weight

1 otor impairment in 11-year-old children with very low birth weight.

2 d more for white than for black infants with very low birth weights.

3 of nosocomial infections among infants with very low birth weights.

4 % vs 5.6%), low birth weight (9.4% vs 9.0%), very low birth weight (1.6% vs 1.5%), and death in the f

5 In unadjusted comparisons, very low birth weight (500-1,499 g) was more likely amon

6 istics information for all 1563 infants with very low birth weights (500 to 1500 g) born from 1987 th

7 Despite their very low birth weight, all were neurologically normal wi

8 dults who were born very preterm and/or with very low birth weight and 106 term-born control subjects

9 r, ultrasound, vaginal birth after cesarean, very low birth weight, and newborn death.

10 tive risk of death among black newborns with very low birth weights as compared with white newborns w

11 ease inhibitors (5 percent) had infants with very low birth weight, as compared with nine women who r

12 outcomes was explained among all births and very low birth weight babies, respectively.

13 eased 17 percent, from 220.3 deaths per 1000 very-low-birth-weight babies born alive (in 1987 through

14 ces in neonatal mortality among infants with very low birth weight (below 1500 g) among NICUs with va

15 The childhood respiratory consequences of very low birth weight (birth weight < or =1,500 g) are i

16 dults who were born very preterm and/or with very low birth weight, cBF volumes were significantly re

17 hors followed to age 8 years a cohort of 384 very low birth weight children from six regional neonata

18 piratory symptoms were twice as common among very low birth weight children.

19 A reduction in early preterm and very-low birth weight could be important clinical and pu

20 Less than one quarter of very-low-birth-weight deliveries occurred in facilities

21 el of care and had a high volume, but 92% of very-low-birth-weight deliveries occurred in urban areas

22 .4, 3.1), respectively; the relative risk of very low birth weight for infants with US-born Black mot

23 the mortality rate among white newborns with very low birth weights (from 261.5 per 1000 to 155.5 per

24 The very-low-birth-weight group reported less alcohol and dr

25 Adults who were born preterm with a very low birth weight have higher blood pressure and imp

26 entilation for the treatment of infants with very low birth weight have not been established.

27 effective use of preventive therapies in the very low birth weight infant population.

28 compassionate use of tin mesoporphyrin in a very low birth weight infant with intrauterine growth re

29 Very low-birth-weight infant infection rates were 16.4%

30 The majority of very low birth weight infants (52%) were discharged on f

31 Very low birth weight infants are at high risk, particul

32 eding support by nurses have higher rates of very low birth weight infants discharged home on human m

33 evel between the dependent variable (rate of very low birth weight infants discharged on "any human m

34 Most conventionally managed very low birth weight infants experience postnatal growt

35 oid (GC) therapy, while approximately 19% of very low birth weight infants receive postnatal GC thera

36 e risk of necrotizing enterocolitis (NEC) in very low birth weight infants receiving indomethacin (IN

37 cently provided reference range for uNGAL in very low birth weight infants shows that normative value

38 Chinese women were less likely to have very low birth weight infants than were whites.

39 exists regarding the best method of managing very low birth weight infants with PDA and whether to em

40 Diminution in risk was greater for very low birth weight infants, amounting to a sevenfold

41 liver disease, necrotizing enterocolitis in very low birth weight infants, and hepatic encephalopath

42 dysplasia (BPD) is a chronic lung disease of very low birth weight infants, associated with oxygen th

43 e nature of dermal structure and function in very low birth weight infants, evidence of mechanical fr

44 Prevention of IC has become a major focus in very low birth weight infants, with fluconazole increasi

45 al palsy in a geographically based cohort of very low birth weight infants.

46 of other morbid conditions in full-term and very low birth weight infants.

47 sk factor for intraventricular hemorrhage in very low birth weight infants.

48 y protein intake may improve growth in these very low birth weight infants.

49 and aggressive administration of protein to very low birth weight infants.

50 possible after birth at 2.5-3.0 g/kg/day in very low birth weight infants; however, there are no lon

51 easure clinical risk and illness severity in very low birth-weight infants.

52 (2500-3999 g), while the admission rate for very low-birth-weight infants (<1500 g) was 844.1 per 10

53 r, double-blind randomized clinical trial in very low-birth-weight infants (birth weight <1500 g) adm

54 Major surgery in very low-birth-weight infants is independently associate

55 al population, but levels of vaccination for very low-birth-weight infants lag slightly behind.

56 life yielded similar short-term outcomes in very low-birth-weight infants regarding safety and effic

57 ctice did not improve outcomes in premature, very low-birth-weight infants requiring a transfusion.

58 our weeks of age in 371 ventilator-dependent very-low-birth-weight infants (501 to 1500 g) who had re

59 th a high level of care and a high volume of very-low-birth-weight infants (more than 100 per year),

60 We studied 5447 very-low-birth-weight infants (those weighing between 40

61 Very-low-birth-weight infants (those weighing less than

62 ree days of life and compared them with 7606 very-low-birth-weight infants born at centers in the net

63 We compared a cohort of 242 survivors among very-low-birth-weight infants born between 1977 and 1979

64 The neonatal mortality rate among all very-low-birth-weight infants decreased 17 percent, from

65 among black infants, the mortality rate for very-low-birth-weight infants did not change significant

66 occurring within 72 hours after birth) among very-low-birth-weight infants have changed in recent yea

67 Very-low-birth-weight infants have high levels of duoden

68 proportionate number of low-birth-weight and very-low-birth-weight infants in the United States, in p

69 Mortality rates among very-low-birth-weight infants varied according to both t

70 Mortality among very-low-birth-weight infants was lowest for deliveries

71 assess neonatal mortality rates among 48,237 very-low-birth-weight infants who were born in Californi

72 lation in terms of the pulmonary outcome for very-low-birth-weight infants without an increase in the

73 ver the past 2 decades on the development of very-low-birth-weight infants' oral feeding skills.

74 such facilities might reduce mortality among very-low-birth-weight infants.

75 ious levels of care and different volumes of very-low-birth-weight infants.

76 gulase-negative staphylococcal infections in very-low-birth-weight infants.

77 ncommon but potentially lethal problem among very-low-birth-weight infants.

78 rcent of low-birth-weight and 4.3 percent of very-low-birth-weight infants.

79 and oligodendrocytes, in preterm babies with very low birth weight is associated with decreased cereb

80 The rate of births at very low birth weight (< 1,500 g) decreased by 6% in the

81 Infant low birth weight and very low birth weight (< 1,500 g) risks were also reduce

82 Systemic candidiasis affects 1.6 to 4.5% of very low birth weight (</= 1,500 g) infants.

83 tion of the low-birth-weight babies having a very low birth weight (<1,500 g) in the more recent birt

84 birth weight (less-than-or-equal 2500 g) and very low birth weight (<1500 g) among infants conceived

85 infants born to both groups; and the rate of very low birth weight (<1500 g) was 2 percent for the gr

86 n a weekend concentration of high-mortality, very low-birth-weight (<1500 g) births.

87 on 422 duodenal aspirates collected from 122 very-low-birth-weight (<1,500-g) newborns, at the time o

88 Very-low-birth-weight men, but not women, were significa

89 Prophylactic GM-CSF in the very low birth weight neonate may reduce the incidence o

90 en suggested as a way to reduce mortality in very low birth weight neonates.

91 igned for pediatric patients; and surgery in very low birth weight neonates.

92 mo corrected age for a historical cohort of very-low-birth-weight neonates (<1250 g) who were admitt

93 ohort and a restricted subcohort of preterm, very low birth weight (P-VLBW) infants.

94 Very-low-birth-weight participants had a lower mean IQ (

95 Educational disadvantage associated with very low birth weight persists into early adulthood.

96 Very low birth weight preterm newborns are susceptible t

97 A multicentered clinical trial found that very low-birth weight preterm infants given bovine lacto

98 double-blind, randomized controlled study of very-low-birth-weight preterm neonates randomly allocate

99 Outcomes included low or very low birth weight, preterm birth, and intrauterine g

100 The very low birth weight rate (<1,500 g) was 2.6% for infan

101 have disparate moderate rates but equivalent very low birth weight rates.

102 protease inhibitors and an increased risk of very low birth weight requires confirmation.

103 ; 95% confidence interval [CI], 1.3-2.3) and very low birth weight (RR, 1.9; 95% CI, 1.3-2.7) than wi

104 Heavy growth of E. coli had a higher risk of very low birth weight than light growth (RR, 2.4; 95% CI

105 The authors considered very low birth weight (VLBW) (<1,500 g), low birth weigh

106 ded particulates (TSP) and risk for having a very low birth weight (VLBW) baby, i.e., one weighing le

107 Premature children born with very low birth weight (VLBW) can suffer chronic hypoxic

108 Very low birth weight (VLBW) infants are at risk for chi

109 Very low birth weight (VLBW) infants are dependent on to

110 Fifty-two term infants and 58 very low birth weight (VLBW) infants without significant

111 ving infants born very preterm (VPT) or with very low birth weight (VLBW) is necessary to guide clini

112 ry preterm (VPT) at 32 weeks or less or with very low birth weight (VLBW) of 1250 g or less.

113 Infants born at very low birth weight (VLBW) require high levels of nurs

114 Low birth weight, very low birth weight (VLBW), preterm birth, and very pr

115 eton birth categories: 450 fetal deaths; 782 very low birth weight (VLBW, < 1,500 g); 802 moderately

116 extremely low birth weight (ELBW, <1000 g), very low birth weight (VLBW, 1000-1499 g), moderately lo

117 or morphometric analysis was performed on 50 very low birth weight (VLBW, birth weight </=1500 g), 49

118 The authors examined the relation between very low birth weight (VLBW: < 1,500 g) and possible dev

119 olitis represent a high-risk subgroup of the very low-birth-weight (VLBW) (<1500 g) population that w

120 improvement (CQI) projects aimed at reducing very low-birth-weight (VLBW) infant morbidities.

121 splasia (BPD) remains a serious morbidity in very low-birth-weight (VLBW) infants (<1500 g).

122 end of antibiotic use among all hospitalized very low-birth-weight (VLBW) infants across Canada and t

123 inatal regionalization have recommended that very low-birth-weight (VLBW) infants be born at highly s

124 ) is typically benign in term infants but in very low-birth-weight (VLBW) infants can cause pneumonit

125 The annual volume of deliveries of very low-birth-weight (VLBW) infants has a greater effec

126 Preterm very low-birth-weight (VLBW) infants have a high prevale

127 Importance: For many very low-birth-weight (VLBW) infants, there is insuffici

128 can cause serious morbidity and mortality in very low-birth-weight (VLBW) infants.

129 ast milk can lead to severe acute illness in very low-birth-weight (VLBW) preterm infants.

130 rt study from January 2010 to February 2014, very low-birth-weight (VLBW, </=1500 g) infants, within

131 ent how parents adapt to the experience of a very low-birth-weight (VLBW; <1500 g) birth despite soci

132 Recent nutritional research in very-low-birth-weight (VLBW) infants is focused on the p

133 f initiation of parenteral lipid infusion to very-low-birth-weight (VLBW) infants varies widely among

134 sure total body water (TBW) was evaluated in very-low-birth-weight (VLBW) infants.

135 entricular hemorrhage (IVH) are common among very-low-birth-weight (VLBW) infants.

136 irth weight ([LBW] 1.8 to 2.24 kg) and three very low birth weight ([VLBW] < or = 1.36 kg) infants, f

137 fections are commonly present in preterm and very low-birth-weight (VLWB) infants and might contribut

138 dults who were born very preterm and/or with very low birth weight was specifically associated with b

139 survival without disability in children with very low birth weights who were assessed at 5 years.

140 mounting to a sevenfold reduction in risk of very low birth weight with first trimester supplementati

141 Fewer very-low-birth-weight young adults than normal-birth-wei